DNTH - Dianthus Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DNTH is currently covered by 5 analysts with an average price target of $34.02. This is a potential upside of $15.8 (86.72%) from yesterday's end of day stock price of $18.22.

Dianthus Therapeutics's activity chart (see below) currently has 0 price targets and 16 ratings on display. The stock rating distribution of DNTH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.67% with an average time for these price targets to be met of 43.8 days.

Highest price target for DNTH is $56, Lowest price target is $36, average price target is $44.6.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 28-Sep-2023.

Best performing analysts who are covering DNTH - Dianthus Therapeutics:

Laura Chico Swayampakula Ramakanth Steven Seedhouse Leland Gershell Maury Raycroft

Currently out of the existing stock ratings of DNTH, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$21.69 (118.46%)

$40

7 months 5 days ago
(11-Nov-2024)

0/4 (0%)

$12.25 (44.14%)

Buy

$52

$33.69 (184.00%)

$48

7 months 5 days ago
(11-Nov-2024)

0/2 (0%)

$24.25 (87.39%)

Buy

$56

$37.69 (205.84%)

$51

7 months 8 days ago
(08-Nov-2024)

1/3 (33.33%)

$26.94 (92.70%)

132

Buy

$36

$17.69 (96.61%)

$38

10 months 7 days ago
(09-Aug-2024)

2/5 (40%)

$8.5 (30.91%)

45

Buy

$39

$20.69 (113.00%)

$22

1 years 2 months 25 days ago
(22-Mar-2024)

1/2 (50%)

$7.06 (22.10%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DNTH (Dianthus Therapeutics) average time for price targets to be met?

On average it took 43.8 days on average for the stock forecasts to be realized with a an average price target met ratio 24.67

Which analyst has the current highest performing score on DNTH (Dianthus Therapeutics) with a proven track record?

LAURA CHICO

Which analyst has the current lower performing score on DNTH (Dianthus Therapeutics) with a proven track record?

MAURY RAYCROFT

Which analyst has the most public recommendations on DNTH (Dianthus Therapeutics)?

Laura Chico works at WEDBUSH and has 22 price targets and 12 ratings on DNTH

Which analyst is the currently most bullish on DNTH (Dianthus Therapeutics)?

Steven Seedhouse with highest potential upside - $37.69

Which analyst is the currently most reserved on DNTH (Dianthus Therapeutics)?

Laura Chico with lowest potential downside - $17.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?